Method and device for quantifying spatial variation and correlation of regional lymphatic measurements

By quantifying the spatial changes and correlation methods of regional glucolymph measurements, fMRI technology and two-sample t-test were used to solve the problem of insufficient research on glucolymph systems in SCA3, and the abnormal glucolymph system patterns in specific areas of the brain were achieved. Revealing of quantitative assessment and correlation between disease progression.

CN118799310BActive Publication Date: 2024-11-15CHINA JAPAN FRIENDSHIP HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411266406.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-11-15
Estimated Expiration
2044-09-11

AI Technical Summary

Technical Problem

The prior art studies on the glial lymphatic system of spinal cerebellar ataxia type 3 (SCA3) are relatively limited, and it is difficult to deeply understand the correlation between its pathophysiology and disease progression.

Method used

Using the method of quantifying the spatial change and correlation of regional glial lymph measurement, brain image data is obtained through fMRI technology, data preprocessing and registration are performed, brain regions are defined, BOLD signals and CSF signals are extracted, and csf-gBOLD coupling index is calculated. The two-sample t-test method was used to compare differences between healthy controls and SCA3 patients, revealing abnormal patterns of the glial lymphatic system in specific areas of the brain.

Benefits of technology

The abnormal pattern of the glioplasty system in specific areas of the brain of SCA3 patients was quantitatively and accurately evaluated, revealing its correlation with disease progression, and providing an in-depth understanding of SCA3 pathophysiology.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118799310B_ABST
    Figure CN118799310B_ABST
Patent Text Reader

Abstract

Disclosed are a method and device for quantifying the spatial variation and correlation of regional glymphatic measurements. The present invention obtains an fMRI image of a subject, obtains a T1-weighted anatomical image of the subject, defines and divides the anterior, middle, posterior and cerebellar regions of the brain, generates a mask, converts and aligns the cortical gray matter mask, performs CSF masking, quantitatively extracts gBOLD signals and CSF signals, analyzes the spatial variation and correlation of indicators in healthy control group HCs and SCA3 patients, and uses a two-sample t-test method to compare the differences in various indicators between HCs and SCA3 patients, thereby revealing the pattern abnormalities of the glymphatic system in specific brain regions of patients with spinocerebellar ataxia type 3, and quantitatively and accurately assessing its correlation with the disease process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical image processing, and in particular to a method for quantifying the spatial variation and correlation of regional jelly lymphatic measurements, and a device for quantifying the spatial variation and correlation of regional jelly lymphatic measurements. Background Art

[0002] Spinocerebellar ataxia type 3 (also known as Machado-Joseph disease, or SCA3 / MJD) is a common autosomal dominant cerebellar ataxia among neurodegenerative diseases. SCA3 patients usually present with motor and non-motor symptoms, such as pyramidal signs, extrapyramidal symptoms, cognitive decline, and rapid eye movement behavior disorder. The pathogenesis of the disease is related to protein misfolding, which is caused by the expansion of CAG repeat sequences in the coding region of the ATXN3 gene on chromosome 14, which produces abnormal polyglutamine proteins. This disorder breaks the balance between protein production and clearance, thereby impairing cell function and inducing neuronal death. Maintaining the homeostasis of the brain environment is essential for clearing these abnormal proteins, because its imbalance affects the cellular environment, triggers neuroinflammation, and drives the complex pathological evolution and progression of the disease. In addition, the key pathological processes of SCA3 also include enhanced inflammatory response, accumulation of metabolic wastes caused by mitochondrial dysfunction, and imbalanced regulation of cellular stress responses.

[0003] Considering these pathological processes, the brain's waste removal mechanisms, especially clearance through the glymphatic system, are critical for maintaining a healthy nervous system. However, limited research has been conducted on the glymphatic system in SCA3. Therefore, a deeper understanding of the pathophysiology of SCA3 is of particular importance. This study aimed to investigate the abnormal functional patterns of the glymphatic system in patients with SCA3 and investigate its impact on the development and progression of the disease. Summary of the invention

[0004] In order to overcome the defects of the prior art, the technical problem to be solved by the present invention is to provide a method for quantifying the spatial variation and correlation of regional glymphatic measurements, which can reveal the pattern abnormalities of the glymphatic system in specific brain regions of patients with spinocerebellar ataxia type 3 and quantitatively and accurately evaluate its correlation with the disease process.

[0005] The technical solution of the present invention is: the method for quantifying the spatial variation and correlation of regional colloid lymphatic measurements comprises the following steps:

[0006] (1) Obtaining fMRI (functional Magnetic Resonance Imaging) images of subjects: Using functional magnetic resonance imaging (fMRI) technology to obtain brain image data of subjects and perform data preprocessing;

[0007] (2) Obtain T1-weighted anatomical images of the subjects: register the fMRI images with high-resolution T1-weighted structural MRI images, and then register the images to the MNI-152 (Montreal Neurological Institute 152 Template) standard space for inter-group comparison and statistical analysis;

[0008] (3) Define and divide the anterior, middle, posterior, and cerebellum regions of the brain and generate masks;

[0009] (4) Cortical gray matter mask conversion and alignment: Using the conversion matrix obtained previously in the registration process, the AAL2 (Automated Anatomical Labeling 2) region definitions in the standard space are converted to the individual functional space; the converted masks are visually inspected so that they are accurately aligned with the preprocessed functional images;

[0010] (5) CSF (Cerebrospinal Fluid) mask: The bottom slices of the fMRI images were selected, which contained the cerebellum of all subjects. The CSF region was automatically detected based on the features in the image, and the CSF region was corrected on the selected slices of the fMRI images by visual inspection based on the knowledge of brain anatomy.

[0011] (6) Quantitative extraction of gBOLD signals and CSF signals: Using the defined mask, the BOLD signals of the anterior, middle, posterior and cerebellar regions of the brain are extracted from the preprocessed fMRI data. These signals are used for subsequent quantitative analysis and comparison.

[0012] (7) Analyze the spatial variation and correlation of indicators in healthy control HCs and SCA3 (Spinocerebellar Ataxia Type 3) patients: Calculate the csf-gBOLD (Cerebrospinal Fluid-Global Blood Oxygen Level Dependent) coupling index of the anterior brain, middle brain, posterior brain, and cerebellum in HCs and SCA3 patients, and compare the spatial variation and difference of the coupling index of each subject to identify the differences in coupling patterns related to SCA3;

[0013] (8) The two-sample t-test method was used to compare the differences in various indicators between HCs and SCA3 patients: to evaluate the correlation of various indicators in HCs and SCA3 patients.

[0014] The present invention obtains fMRI images of subjects, obtains T1-weighted anatomical images of subjects, defines and divides the front, middle, posterior and cerebellum regions of the brain, generates masks, converts and aligns cortical gray matter masks, performs CSF masks, quantitatively extracts gBOLD signals and CSF signals, analyzes spatial changes and correlations of indicators in healthy control group HCs and SCA3 patients, and compares the differences in various indicators between HCs and SCA3 patients using a two-sample t-test method, thereby revealing the pattern abnormalities of the glymphatic system in specific brain regions of patients with spinocerebellar ataxia type 3, and quantitatively and accurately evaluating its correlation with the disease process.

[0015] Also provided is a device for quantifying spatial variation and correlation of regional lymphatic measurements, comprising:

[0016] An fMRI image acquisition module configured to acquire fMRI images of a subject: acquire brain image data of the subject using functional magnetic resonance imaging (fMRI) technology, and perform data preprocessing;

[0017] a T1 image acquisition module configured to acquire T1-weighted anatomical images of the subject: registering the fMRI images with the high-resolution T1-weighted structural MRI images, and then registering the images to the MNI-152 standard space for inter-group comparison and statistical analysis;

[0018] a mask generation module configured to define and partition the anterior, middle, posterior, and cerebellum regions of the brain and generate masks;

[0019] A transformation and alignment module configured to perform cortical gray matter mask transformation and alignment: transform the AAL2 region definitions in standard space to individual functional space using the transformation matrix previously obtained in the registration process; visually inspect the transformed masks to ensure that they are accurately aligned with the preprocessed functional images, and manually adjust or re-register any mismatches or errors;

[0020] a CSF masking module configured to perform CSF masking by selecting the bottom slices of the fMRI images that contain the cerebellum of all subjects, automatically detecting the CSF region based on features in the images, and manually correcting the CSF region on the selected slices of the fMRI images by visual inspection and based on knowledge of brain anatomy;

[0021] A quantitative extraction module, which is configured to quantitatively extract gBOLD signals and CSF signals: using the defined mask, the BOLD signals of the anterior, middle, posterior and cerebellar regions of the brain are extracted from the preprocessed fMRI data, and these signals are used for subsequent quantitative analysis and comparison;

[0022] The analysis module is configured to analyze the spatial variation and correlation of the indices in healthy control HCs and SCA3 patients: the csf-gBOLD coupling index of the anterior brain, middle brain, posterior brain, and cerebellum is calculated in HCs and SCA3 patients, and the spatial variation and difference of the coupling index of each subject are compared to identify the differences in coupling patterns related to SCA3;

[0023] Statistical analysis module, which is configured to compare the differences of each indicator between HCs and SCA3 patients using two-sample t-test method: to evaluate the correlation of each indicator in HCs and SCA3 patients. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 A flow chart showing a method for quantifying spatial variation and correlation of regional lymphatic measurements according to the present invention. DETAILED DESCRIPTION

[0025] like Figure 1 As shown, this method to quantify the spatial variation and correlation of regional lymphatic measurements includes the following steps:

[0026] (1) Obtaining fMRI images of subjects: Using functional magnetic resonance imaging (fMRI) technology to obtain brain image data of subjects and perform data preprocessing;

[0027] (2) Obtain T1-weighted anatomical images of the subjects: align the fMRI images with high-resolution T1-weighted structural MRI images, and then align the images to the MNI-152 standard space for inter-group comparison and statistical analysis;

[0028] (3) Define and divide the anterior, middle, posterior, and cerebellum regions of the brain and generate masks;

[0029] (4) Cortical gray matter mask conversion and alignment: Using the conversion matrix obtained previously in the registration process, the AAL2 region definitions in the standard space are converted to the individual functional space; the converted masks are visually inspected so that they are accurately aligned with the preprocessed functional images;

[0030] (5) CSF mask: The bottom slices of the rs-fMRI images were selected, which contained the cerebellum of all subjects. The CSF region was automatically detected based on the features in the image, and the CSF region was corrected on the selected slices of the fMRI images by visual inspection based on the knowledge of brain anatomy.

[0031] (6) Quantitative extraction of gBOLD signals and CSF signals: Using the defined mask, the BOLD signals of the anterior, middle, posterior and cerebellar regions of the brain are extracted from the preprocessed fMRI data. These signals are used for subsequent quantitative analysis and comparison.

[0032] (7) Analyze the spatial variation and correlation of the indicators in healthy control HCs and SCA3 patients: Calculate the csf-gBOLD coupling index in the anterior, middle, posterior, and cerebellum of the brain in HCs and SCA3 patients, and compare the spatial variation and differences of the coupling index of each subject to identify differences in coupling patterns related to SCA3;

[0033] (8) The two-sample t-test method was used to compare the differences in various indicators between HCs and SCA3 patients: to evaluate the correlation of various indicators in HCs and SCA3 patients.

[0034] The present invention obtains fMRI images of subjects, obtains T1-weighted anatomical images of subjects, defines and divides the front, middle, posterior and cerebellum regions of the brain, generates masks, converts and aligns cortical gray matter masks, performs CSF masks, quantitatively extracts gBOLD signals and CSF signals, analyzes spatial changes and correlations of indicators in healthy control group HCs and SCA3 patients, and compares the differences in various indicators between HCs and SCA3 patients using a two-sample t-test method, thereby revealing the pattern abnormalities of the glymphatic system in specific brain regions of patients with spinocerebellar ataxia type 3, and quantitatively and accurately evaluating its correlation with the disease process.

[0035] Preferably, before step (1), the subjects are screened, genetic testing is performed, and screening is performed using assessment tools including the Scale for the Assessment and Rating of Ataxia SARA (Scale for the Assessment and Rating of Ataxia) and the International Cooperative Ataxia Rating Scale ICARS (International Cooperative Ataxia Rating Scale), and then a psychiatric assessment including the Self-Rating Anxiety Scale SAS (Self-Rating Anxiety Scale) and the Self-Rating Depression Scale SDS (Self-Rating Depression Scale) is performed, and then the patient's sleep quality is assessed using the Self-Rating Sleep Scale SRSS (Self-Rating Sleep Scale).

[0036] Preferably, in step (1), the subject is required to lie in the scanner, keep the head still, and minimize body movement.

[0037] Preferably, in step (1), the preprocessing process includes: slice time correction, adjusting the acquisition time difference of different slices in each volume to ensure their temporal consistency; motion correction, correcting the head movement of the subject during the scanning process to ensure the stability of the image sequence; skull removal, removing the non-brain tissue area of ​​the skull from the fMRI image to reduce interference with subsequent analysis; spatial smoothing, using a Gaussian filter to smooth the image to reduce noise and improve the signal-to-noise ratio, using a 4mm FWHM (Full Width at Half Maximum) kernel; bandpass filtering, applying a 0.01-0.1Hz bandpass filter to remove high-frequency noise and low-frequency drift, retaining signals related to neural activity; time trend removal, eliminating linear and quadratic time trends in the image, which are caused by heating of the scanner or physiological processes of the subject.

[0038] Preferably, in step (3), the anterior, middle, posterior and cerebellum regions of the brain are defined and divided as follows: using the AAL2 atlas, the brain regions are divided into anterior, middle and posterior regions according to anatomical positions and functional characteristics, and the cerebellum region is defined and divided separately.

[0039] Preferably, in step (3), mask generation includes: generating corresponding masks of the front, middle, posterior and cerebellum of the brain for each subject according to the AAL2 atlas, and these masks are used to extract BOLD signals of specific regions from fMRI data.

[0040] Preferably, in step (8), the data are z-score standardized and age and gender are adjusted; and the relationship between the neuropsychological assessment of SCA3 patients and the coupling strength of a / m / p / cb / gBOLD-CSF (a / m / p / cb / gBOLD-CSF refers to anterior / medial / posterior / cerebellum / Cerebrospinal Fluid - global Blood Oxygen Level Dependent signal, anterior / midline / posterior / cerebellum / cerebrospinal fluid) is evaluated by regression analysis.

[0041] A person skilled in the art can understand that all or part of the steps in the above-mentioned embodiment method can be completed by instructing the relevant hardware through a program, and the program can be stored in a computer-readable storage medium. When the program is executed, it includes the steps of the above-mentioned embodiment method, and the storage medium can be: ROM / RAM, disk, CD, memory card, etc. Therefore, corresponding to the method of the present invention, the present invention also includes a device for quantifying the spatial variation and correlation of regional colloid lymphatic measurements, which is usually represented in the form of functional modules corresponding to the steps of the method. The device includes:

[0042] An fMRI image acquisition module configured to acquire fMRI images of a subject: acquire brain image data of the subject using functional magnetic resonance imaging (fMRI) technology, and perform data preprocessing;

[0043] a T1 image acquisition module configured to acquire T1-weighted anatomical images of the subject: registering the rs-fMRI images with the high-resolution T1-weighted structural MRI images, and then registering the images to the MNI-152 standard space for inter-group comparison and statistical analysis;

[0044] a mask generation module configured to define and partition the anterior, middle, posterior, and cerebellum regions of the brain and generate masks;

[0045] A transformation and alignment module configured to perform cortical gray matter mask transformation and alignment: transform the AAL2 region definitions in standard space to individual functional space using the transformation matrix previously obtained in the registration process; visually inspect the transformed masks to ensure that they are accurately aligned with the preprocessed functional images, and manually adjust or re-register any mismatches or errors;

[0046] a CSF masking module configured to perform CSF masking by selecting the bottom slices of the rs-fMRI images that contain the cerebellum of all subjects, automatically detecting the CSF region based on features in the images, and manually correcting the CSF region on the selected slices of the fMRI images by visual inspection and based on knowledge of brain anatomy;

[0047] A quantitative extraction module, which is configured to quantitatively extract gBOLD signals and CSF signals: using the defined mask, the BOLD signals of the anterior, middle, posterior and cerebellar regions of the brain are extracted from the preprocessed fMRI data, and these signals are used for subsequent quantitative analysis and comparison;

[0048] The analysis module is configured to analyze the spatial variation and correlation of the indices in healthy control HCs and SCA3 patients: the csf-gBOLD coupling index of the anterior brain, middle brain, posterior brain, and cerebellum is calculated in HCs and SCA3 patients, and the spatial variation and difference of the coupling index of each subject are compared to identify the differences in coupling patterns related to SCA3;

[0049] Statistical analysis module, which is configured to compare the differences of each indicator between HCs and SCA3 patients using two-sample t-test method: to evaluate the correlation of each indicator in HCs and SCA3 patients.

[0050] Preferably, in the fMRI image acquisition module, the subject is required to lie in the scanner, keep the head still, and minimize body movement.

[0051] Preferably, in the fMRI image acquisition module, the preprocessing process includes: slice time correction, adjusting the acquisition time difference of different slices in each volume to ensure their temporal consistency; motion correction, correcting the head movement of the subject during the scan to ensure the stability of the image sequence; skull removal, removing the non-brain tissue area of ​​the skull from the fMRI image to reduce interference with subsequent analysis; spatial smoothing, using a Gaussian filter to smooth the image, reduce noise and improve the signal-to-noise ratio, using a 4mm FWHM kernel; bandpass filtering, applying a 0.01-0.1Hz bandpass filter to remove high-frequency noise and low-frequency drift, retaining signals related to neural activity; time trend removal, eliminating linear and quadratic time trends in the image, which are caused by heating of the scanner or physiological processes of the subject.

[0052] Preferably, in the mask generation module, the anterior, middle, posterior and cerebellum regions of the brain are defined and divided as follows: using the AAL2 atlas, the brain regions are divided into anterior, middle and posterior regions according to anatomical positions and functional characteristics, and the cerebellum region is also defined and divided separately.

[0053] Preferably, in the mask generation module, mask generation includes: generating corresponding masks of the front, middle, back and cerebellum of the brain for each subject according to the AAL2 atlas, and these masks are used to extract BOLD signals of specific areas from fMRI data.

[0054] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any simple modification, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention are still within the protection scope of the technical solution of the present invention.

Claims

1. Methods to quantify spatial variation and correlation of regional glial lymphatic measurements, characterized by: It includes the following steps: (1) Obtaining fMRI images of subjects: Using functional magnetic resonance imaging (fMRI) technology to obtain brain image data of subjects and perform data preprocessing; (2) Obtain T1-weighted anatomical images of the subjects: rs-fMRI images were registered with high-resolution T1-weighted structural MRI images, and then the images were registered to the MNI-152 standard space for inter-group comparison and statistical analysis; (3) Define and divide the anterior, middle, posterior, and cerebellum regions of the brain and generate masks; (4) Cortical gray matter mask conversion and alignment: Using the conversion matrix obtained previously in the registration process, the AAL2 region definition in the standard space is converted to the individual functional space; Visually inspect the converted masks so that they are accurately aligned with the preprocessed functional images; (5) CSF mask: The bottom slices of the rs-fMRI images were selected, which contained the cerebellum of all subjects. The CSF region was automatically detected based on the features in the image, and the CSF region was corrected on the selected slices of the fMRI images by visual inspection based on the knowledge of brain anatomy. (6) Quantitative extraction of gBOLD signals and CSF signals: Using the defined mask, the BOLD signals of the anterior, middle, posterior and cerebellar regions of the brain are extracted from the preprocessed fMRI data. These signals are used for subsequent quantitative analysis and comparison. (7) Analyze the spatial variation and correlation of the indicators in healthy control HCs and SCA3 patients: Calculate the csf-gBOLD coupling index in the anterior, middle, posterior, and cerebellum of the brain in HCs and SCA3 patients, and compare the spatial variation and differences of the coupling index of each subject to identify differences in coupling patterns related to SCA3; (8) The two-sample t-test method was used to compare the differences in various indicators between HCs and SCA3 patients: to evaluate the correlation of various indicators in HCs and SCA3 patients.

2. The method for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 1, characterized in that: Prior to step (1), the subjects are screened, genetic testing is performed, and screening is performed using assessment tools including the Ataxia Assessment Scale SARA and the International Collaborative Ataxia Rating Scale ICARS. A psychiatric assessment is then performed including the Self-Rating Anxiety Scale SAS and the Self-Rating Depression Scale SDS. The sleep quality of the patients is then assessed using the Self-Rating Sleep Scale SRSS.

3. The method for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 2, characterized in that: In step (1), the subject is required to lie in the scanner with his head fixed and his body still.

4. The method for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 3, characterized in that: In step (1), the preprocessing process includes: slice time correction, adjusting the acquisition time difference of different slices in each volume to ensure their temporal consistency; motion correction, correcting the head movement of the subject during the scanning process to ensure the stability of the image sequence; skull removal, removing the non-brain tissue area of ​​the skull from the fMRI image to reduce interference with subsequent analysis; spatial smoothing, using a Gaussian filter to smooth the image to reduce noise and improve the signal-to-noise ratio, using a 4mm FWHM kernel; bandpass filtering, applying a 0.01-0.1Hz bandpass filter to remove high-frequency noise and low-frequency drift, retaining signals related to neural activity; time trend removal, eliminating linear and quadratic time trends in the image, which are caused by heating of the scanner or physiological processes of the subject.

5. The method for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 4, characterized in that: In the step (3), the anterior, middle, posterior and cerebellum regions are defined and divided as follows: using the AAL2 atlas, the brain regions are divided into the anterior, middle and posterior regions according to their anatomical positions and functional characteristics, and the cerebellum region is defined and divided separately.

6. The method for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 5, characterized in that: In the step (3), the mask generation includes: generating corresponding masks of the front, middle, posterior and cerebellum of the brain for each subject according to the AAL2 atlas, and these masks are used to extract BOLD signals of specific regions from fMRI data.

7. The method for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 6, characterized in that: In step (8), the data were z-score standardized and age and gender were adjusted; regression analysis was used to evaluate the relationship between neuropsychological assessment and a / m / p / cb / gBOLD-CSF coupling strength in SCA3 patients.

8. A device for quantifying spatial variation and correlation of regional lymphatic measurements, characterized by: It includes: An fMRI image acquisition module configured to acquire fMRI images of a subject: acquire brain image data of the subject using functional magnetic resonance imaging (fMRI) technology, and perform data preprocessing; a T1 image acquisition module configured to acquire T1-weighted anatomical images of the subject: registering the rs-fMRI images with the high-resolution T1-weighted structural MRI images, and then registering the images to the MNI-152 standard space for inter-group comparison and statistical analysis; a mask generation module configured to define and partition the anterior, middle, posterior, and cerebellum regions of the brain and generate masks; A transformation and alignment module configured to perform cortical gray matter mask transformation and alignment: the AAL2 region definitions in the standard space are transformed into the individual functional space using the transformation matrix previously obtained in the registration process; Visually inspect the converted masks to ensure that they are accurately aligned with the preprocessed functional images; a CSF masking module configured to perform CSF masking by selecting the bottom slices of the rs-fMRI images that contain the cerebellum of all subjects, automatically detecting the CSF region based on features in the images, and correcting the CSF region on the selected slices of the fMRI images by visual inspection and based on knowledge of brain anatomy; A quantitative extraction module, which is configured to quantitatively extract gBOLD signals and CSF signals: using the defined mask, the BOLD signals of the anterior, middle, posterior and cerebellar regions of the brain are extracted from the preprocessed fMRI data, and these signals are used for subsequent quantitative analysis and comparison; The analysis module is configured to analyze the spatial variation and correlation of the indices in healthy control HCs and SCA3 patients: the csf-gBOLD coupling index of the anterior brain, middle brain, posterior brain, and cerebellum is calculated in HCs and SCA3 patients, and the spatial variation and difference of the coupling index of each subject are compared to identify the differences in coupling patterns related to SCA3; Statistical analysis module, which is configured to compare the differences of each indicator between HCs and SCA3 patients using two-sample t-test method: to evaluate the correlation of each indicator in HCs and SCA3 patients.

9. The device for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 8, characterized in that: In the fMRI image acquisition module, the preprocessing process includes: slice time correction, adjusting the acquisition time differences of different slices in each volume to ensure their temporal consistency; motion correction, correcting the head movement of the subject during the scan to ensure the stability of the image sequence; skull removal, removing the non-brain tissue area of ​​the skull from the fMRI image to reduce interference with subsequent analysis; spatial smoothing, using a Gaussian filter to smooth the image to reduce noise and improve the signal-to-noise ratio, using a 4mm FWHM kernel; bandpass filtering, applying a 0.01-0.1Hz bandpass filter to remove high-frequency noise and low-frequency drift, retaining signals related to neural activity; time trend removal, eliminating linear and quadratic time trends in the image, which are caused by heating of the scanner or physiological processes of the subject.

10. The device for quantifying spatial variation and correlation of regional lymphatic measurements according to claim 9, characterized in that: In the mask generation module, mask generation includes: generating corresponding masks of the front, middle, back and cerebellum of the brain for each subject according to the AAL2 atlas, and these masks are used to extract BOLD signals of specific areas from fMRI data.